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Abstract21
A series of recent studies have suggested the haematopoietic niche of the bone marrow as a22
major reservoir for parasite replication and the development of transmission stages. However23
significant knowledge gaps remain in our understanding in the host parasite interactions,24
pathophysiology and implications for treatment and diagnosis of such reservoir. Here, we25




Outside of Sub-Saharan Africa, Plasmodium vivax dominates the malaria public health29
burden. In these regions it accounts for 41% of all malaria cases resulting in 35% of the30
global population living at risk of P. vivax infection [1, 2]. Even in Sub-Saharan Africa, an31
increase of P. vivax cases has been observed despite high frequency of Duffy-negative alleles32
[3]. In the Brazilian Amazon region, P. vivax is the main species causing malaria and33
responsible for more than 85% of all cases [1]. In general, P. vivax persists in areas that34
succeeded to eliminate P. falciparum by malaria control programs [4]. However, major35
knowledge and tool gaps remain in P. vivax research as the focus so far has been on P.36
falciparum.37
For a long time, P. vivax research was neglected due to failure to establish an in vitro38
culture system and apparently low prevalence of severe cases compared to P. falciparum [5-39
7]. Presence of all stages in the blood circulation, and therefore assumed lack of sequestration,40
has contributed to the long-standing misconception that P. vivax is a benign parasite [8].41
However, recent data have demonstrated that late asexual blood stage P. vivax parasites are42
capable of cytoadhering to endothelial host receptors [7, 9], and that they are less abundant in43
blood circulation than younger stages in P. vivax patients [7, 10]. Estimation of parasite44
biomass based on circulating biomarkers indicates existence of a predominant parasite45
biomass outside of circulation that is not captured by peripheral P. vivax parasitemia, in46
particular in patients with complicated outcomes [10]. Moreover, a series of recent47
histological studies in P. vivax patients and experimentally infected non-human primates48
(NHP) provides direct evidence for the existence of a major reservoir of P. vivax blood stage49
parasites, both asexual and sexual (gametocytes) in the haematopoietic niche of bone marrow50
and possibly spleen. These recent findings, together with more stringent diagnosis techniques51
of P. vivax infection suggesting a similar risk of severe disease and death as P. falciparum52
infection [6], strongly argue against the benign nature of P. vivax malaria, especially in53
patients with other comorbidities.54
55
P. vivax biomass in peripheral circulation: the tip of the iceberg?56
P. vivax parasites exhibit a narrow tropism by strictly infecting young reticulocytes. In57
contrast, P. falciparum can infect normocytes even though it also prefers to infect young58
reticulocytes [11-14]. The restriction of P. vivax for young reticulocytes that are exceedingly59
rare in circulation (<2% of all circulating red blood cells) means parasitaemia is greatly60
limited by the abundance of available host cells [6, 15]. Low peripheral parasitaemia and61
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apparent presence of all parasite stages in the blood contradicts numerous reports of vivax62
malaria with severe illness and deaths due to P. vivax infection in all endemic regions [16-20].63
It has been suggested that P. vivax parasites have a lower pyrogenic threshold and hence64
induce a stronger inflammatory response compared to other Plasmodium infections with65
similar or greater parasitaemia [15]. Indeed, the host inflammatory response and endothelial66
activation are greater in patients infected with P. vivax than with other malaria infections [19-67
21].68
It has also been suggested that the peripheral parasitaemia represents only a fraction69
of the total P. vivax parasite biomass. Various indirect lines of evidence support this70
hypothesis. First, several reports from P. vivax patients have shown that the total parasite71
biomass, as define by pvLDH levels in blood, is underestimated by microscopic analysis of72
peripheral blood smears [6, 21]. Second, there is no clear correlation between the burden of73
peripheral parasitaemia and disease severity. Accordingly, a wide range of clinical syndromes74
occurs in P. vivax patients even with modest peripheral parasite counts, in contrast to P.75
falciparum-infected individuals [6, 21-31]. Third, NHP models susceptible to P. vivax76
infection have been very informative in inferring sequestered parasite biomass and77
correlations with pathogenesis [31-34]. A computational model capable to quantify the78
parasite biomass concealed in a tissue reservoir by measuring blood parasitaemia was79
designed by observing the longitudinal dynamics of P. cynomolgi parasitaemia in infected80
Macaca mulatta, a P. vivax simian malaria model [31]. Through the application of this model81
and additional observations made in vivax malaria patients it was inferred that a large82
fraction of parasites is withdrawn from the peripheral circulation early during blood stage83
infection and hidden in a reservoir, with potential role in disease pathogenesis [31, 34].84
Fourth, clinical studies in P. vivax patients and in NHP models demonstrate that this hidden85
parasite population seemingly expands without detection and contributes to disease severity86
[6, 21-34], systemic inflammation [15, 21, 28] and intravascular accumulation of immune87
cells in pulmonary pathologies [28].88
Finally, several studies have reported a biased distribution of asexual forms in blood89
smears of P. vivax patients, with higher prevalence of ring stages compared to trophozoites90
and schizonts in peripheral blood [7, 10]. Likewise, transcriptomic analysis from P. vivax91
blood samples demonstrated a quantitative depletion of transcripts from late asexual and92
immature sexual stages, or gametocytes, in the blood of P. vivax-infected patients [32],93
similar to observations with P. falciparum [35]. At the same time these later asexual stages94
display a higher adhesive capacity compared to young stages, indicating that the latter part of95
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the asexual P. vivax cycle could occur in deep tissues and outside of peripheral circulation [6,96
7, 10]. Specifically, late asexual parasites are able to cytoadhere in vitro to endothelial97
receptors, such as ICAM-1, CD36 and chondroitin sulfate A (CSA), receptors expressed in98
cerebral, pulmonary and placental microvasculature, with a similar strength but lower99
frequency than red blood cells (RBCs) infected with P. falciparum [7, 9, 36, 37].100
101
Emerging evidence for a P. vivax reservoir in the hematopoietic niche of the bone102
marrow103
The reticulocyte population makes only 1–2% of all circulating RBCs [13, 14]. Immature104
reticulocytes are largely confined to the bone marrow (BM, ~0.016% of all enucleated105
erythroid cells in the circulation) and more cytoadhesive (higher expression of adhesion106
molecules such as CD49d and CD44) than circulating reticulocytes. Reticulocytes are formed107
from haematopoietic stem cells and released from the bone marrow niche for final maturation108
in the spleen [11-14, 38, 39]. P. vivax preferentially invades BM resident immature109
reticulocytes making this niche highly advantageous for the parasite. Multiple case reports110
have detected P. vivax at higher parasite biomass in the BM compared to blood, or111
exclusively in BM [12, 25, 40-43]. P. vivax infections after BM transplantation have also112
been reported [27, 44-46], suggesting that BM may represent a pivotal tissue reservoir in P.113
vivax infection.114
A systematic analysis of P. vivax distribution in tissue samples from infected115
splenectomized Aotus and Saimiri monkeys revealed enrichment of gametocytes and116
schizonts in the BM and liver [32]. Together, these organs accounted for about 30% of the117
total parasite burden. 70% of the gametocyte load and 90% of the schizont load was118
accumulated in the BM and liver, suggesting that these tissues are major parasite reservoirs.119
Importantly, in the BM the vast majority of parasites were located in the parenchyma, where120
haematopoiesis takes place. Immunohistochemistry (IHC) analysis revealed that the majority121
of parasites detected by the constitutive marker pLDH (Plasmodium lactate dehydrogenase)122
were negative for antibodies against late sexual (PvLAP5) and asexual stages (PvAMA1)123
markers, indicating the enrichment of early ring stages and immature gametocytes in the BM124
parenchyma [32]. In agreement with these data a recent case report demonstrated enrichment125
of rings, schizonts and gametocytes in BM compared to blood [47]. Together, these studies126
suggest that the BM contributes significantly to the total P. vivax biomass, providing a niche127
for asexual growth and development of gametocyte stages (Figure 1).128
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These findings are in line with similar observations in P. falciparum and the rodent129
malaria parasite P. berghei. Autopsy case studies and analyses of biopsies and aspirates have130
consistently revealed a significant enrichment of P. falciparum immature gametocytes in the131
BM and spleen of infected patients [48-50]. In the BM parenchyma, gametocytes were132
enriched at erythroblast islands before re-entering the circulation [49]. Quantitative imaging133
experiments in the rodent malaria model P. berghei also demonstrated gametocyte134
development in the extravascular niche of the BM and spleen, involving selective tissue135
homing, transmigration across the endothelial barrier and mobile behaviour of mature136
gametocytes [51]. In addition, asexual parasite stages were observed in the extravascular137
environment both in P. falciparum (in human autopsies) and in P. berghei (in infected mice),138
suggesting existence of a genuine extravascular replication cycle in both Plasmodium species139
[51]. Altogether these observations establish infection of the BM haematopoietic niche as a140
new paradigm in Plasmodium biology.141
142
What is the role of the spleen as a parasite reservoir?143
Experimental and clinical studies have demonstrated that P. vivax infection induces a marked144
splenomegaly, with incidence of splenic rupture and death higher than in other malaria145
infections [52-58]. In humans, the spleen contributes to the clearance of damaged and146
infected RBCs, generation of immunity and it changes to parasite antigens expressed on the147
surface of infected RBCs [54, 55]. Examinations of spleen samples from P. vivax patients148
revealed extensive remodelling, enlargement of the white pulp, increased cellularity and large149
numbers of intact P. vivax–infected reticulocytes in the red pulp [22, 54, 55]. In one case150
report, confocal microscopy analysis showed macrophages containing large amounts of151
parasite pigments, but no intact RBCs were detected in macrophages. Interestingly, intense152
proliferation of B cells, plasma cells and plasmablasts in extrafollicular compartments, which153
resembled a B-cell lymphoma phenotype was also observed [22], suggesting that alterations154
in the spleen are linked to acquisition of anti-parasite immunity.155
Initial investigation of P. vivax sequestration in spleen-intact common squirrel156
monkeys (Saimiri sciureus) and night monkeys (Aotus lemurinus lemurinus) identified the157
splenic vasculature as the primary site of P. vivax asexual development, with a high158
proportion of schizont-infected RBCs [33]. The liver and BM appeared as secondary sites for159
trophozoite and schizont accumulation [33] while gametocytes were not analysed. Although160
these observations were based on organ crushes only and the organs were not perfused, a161
recent study in P. vivax-infected Saimiri included one spleen-intact control animal that162
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showed a similar pattern of parasite distribution [34]: spleen contained the highest parasite163
counts followed by the liver, lung and BM. In agreement with the work by Obaldia et al. [32],164
parasites were enriched in BM and liver in the splenectomised animals [34] (Figure 1).165
Splenectomy before infection is an important limitation in these studies, as the significant166
parasite load observed in BM and liver could mask a significant reservoir in the spleen. So far,167
no systematic autopsy case or other tissue biopsy studies of P. vivax-infected patients168
comparing the role of both spleen and BM as potential parasite reservoirs have been169
conducted. In P. falciparum, high numbers of parasites were found in spleen samples from170
autopsies cases [49], however it remains to be determined whether these are viable or present171
within macrophages. In the rodent malaria model the spleen represents the major parasite172
reservoir outside of circulation with significant levels of asexual and gametocyte stages [51].173
In contrast to humans and primates, the adult murine spleen is haematopoietically174
active. However, splenic extramedullary erythropoiesis can also occur in humans during175
specific pathological conditions including malaria. Such mechanism has been suggested to be176
stimulated during vivax malaria to compensate anaemia [59], and it would further support the177
role of the spleen as a parasite reservoir [60-62]. In this scenario, haematopoiesis would take178
place in the red pulp of the spleen before the release of reticulocytes into the circulation. In179
addition, P. vivax infection may also induce a remodelling of uninfected RBCs, resulting in180
their arrest in the spleen. In turn, this could generate a reservoir for parasite invasion. These P.181
vivax-infected reticulocytes may remain trapped in the red pulp by interacting with182
contractile fibroblasts, cells that proliferate during splenic erythropoiesis and surround183
reticulocytes [59, 61].184
185
Sub-patent infection in the hematopoietic reservoir as a source of recurrences?186
The observed concealment of infected RBCs in the haematopoietic system is likely to be187
critical for the parasite to evade immunity and drug pressure, and this reservoir may188
contribute to the observed recurrence patterns in P. vivax infection. Proof-of-principle189
support of this hypothesis comes from the P. berghei model, which – as P. vivax - has a190
preference for young reticulocytes. Mice infected with P. berghei and treated with at least 10191
mg/kg of artemisinin clear peripheral parasitaemia but maintain low level infection rates in192
BM and spleen that initiate recurrence of peripheral parasitaemia [63].193
Case reports also support the hypothesis of P. vivax recurrence from the194
haematopoietic niche. For example, one report from Brazil documented a patient with195
persistent thrombocytopenia and an enlarged spleen who was diagnosed with chronic P. vivax196
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malaria after discovering schizonts in BM aspirate [24]. In another case report, a patient197
developed vigorous vivax malaria with relatively high parasitaemia (1%) 40 days after a198
donor BM transplant [27]. Investigations revealed that the donor was diagnosed with malaria199
11 months before BM collection, and had an asymptomatic recurrence following treatment of200
the first infection [27]. The uncertain origin of homologous vivax recurrences [64], case201
reports of P. vivax parasites detected only in BM aspirates without peripheral blood202
parasitaemia [24, 27, 40-44, 65], reports of vivax infection following sibling allogeneic BM203
transplants [45], and recurrence after autologous BM transplantation [46] further suggest204
presence of sub-patent P. vivax infections in the BM that can lead to recurrence. Hence BM205
could be an alternative source of parasite recurrence upon drug treatment, as opposed to liver206
relapse from quiescent hypnozoite stages. Notably, primaquine and related 8-207
aminoquinolines, the first line treatment against hypnozoites, are prodrugs that require208
activation through an enzymatic pathway that is predominant in liver and BM tissue [66].209
Analysis of recurrence patterns in neurosyphilis patients who underwent malaria210
therapy either through inoculation by P. vivax blood stage or sporozoites provide interesting211
information in that regard [67]. While there is wide variation in recurrence patterns across212
individual patients, parasite dynamics are not significantly different during the first 2 months213
post infection [67], whereas only sporozoite-inoculated infections seem to exhibit recurrent214
parasitaemias weeks after absence of peripheral blood parasites, indicative of relapses from215
liver hypnozoites (Figure 2). Data from other studies performed around the same time as the216
malaria therapies confirm these observations. For example, a study covering around two217
years of observations of general paralysis in patients inoculated with P. vivax trophozoites218
and treated with quinine (30g, 2-4 days), revealed that 2% relapsed up to a month after end of219
treatment [68, 69]. In patients who survived infection after mosquito bites, 18% recurred220
between two to six months and 33% of these recurred more than once [68]. Another study221
comparing P. vivax blood stage versus sporozoite infection reported that both inoculation222
routes lead to 35-40% of recurrences within the first two months after termination of the223
primary infection, while only sporozoite infections recurred beyond that point [70]. Similar to224
the malaria therapy studies, a longitudinal study in rhesus monkeys infected with P.225
cynomolgi showed recurrence in 48% of the monkeys inoculated with trophozoites while226
79% of those infected with sporozoites recurred [71]. In this study, animals who were227
negative by thick smear for 60 days or more underwent splenectomy: 25% of sporozoite-228
infected animals relapsed up to two weeks after splenectomy, while none of the trophozoite-229
infected monkeys did [71].230
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Taken together, comparative data from experimental infections in humans and231
animals indicate that both the blood stage and sporozoite infection routes can exhibit similar232
recurrence patterns, at least during the first 2 months post infection and following (sub-233
curative) drug treatment. On the other hand, the limited data available indicates that234
hypnozoite relapse have a much greater contribution during later phases of infection, which235
together suggests that the BM reservoir and liver hypnozoites are distinct but synergistic236
strategies by which the parasite prolongs infection and thus enhances its transmission success.237
238
What are the implications of P. vivax development in the BM for the host?239
Parasite infection in the haematopoietic niche has implications for malaria pathogenesis,240
diagnosis and treatment. The BM parenchyma is a specialized and complex241
microenvironment that provides a set of molecular, structural and physical cues to regulate242
hematopoietic stem and progenitor cell (HSPC) production [72]. Haematopoiesis is a243
dynamic biological process that can also be responsive and shaped by pathogens during244
infection. HSPCs are capable of responding to pathogens by directly sensing pathogen-245
associated molecule patterns (PAMPs) through their respective pathogen-recognition246
receptors (PRRs). They also express a broad range of cytokines/chemokines receptors, which247
allows them to detect pro-inflammatory signals (DAMPs).248
Recent studies investigating the impact of parasite infection in the BM have focused249
on potential changes in erythropoiesis to understand the pathophysiology of vivax malaria250
anaemia [47, 73]. These changes include altered levels of miRNA transcripts [48] and251
impaired activity of transcription factors, such as GATA1/GATA2 [74, 75], regulating252
erythropoiesis. GATA1/GATA2 changes are mediated by intermediate and non-classical253
monocytes and activation of IFN type I and II signalling pathways in the BM [74]. Similarly,254
IFN-γ is implicated in malarial anaemia in rodent malaria models and can directly cause255
apoptosis of erythroid progenitors in vitro [76]. It has also been suggested that inflammatory256
cytokines produced by macrophages and monocytes in the BM in response to parasite by-257
products promote the dyserythropoiesis observed during malarial anaemia [77]. In P. vivax-258
infected patients lymphopenia and thrombocytopenia are common clinical signs of infection,259
while myeloid cell count (e.g., monocytes and neutrophils) often remain unchanged in the260
peripheral blood [6, 15, 21, 24, 73, 78-81]. Although the level of cytokines implicated in the261
expansion of the megakaryocyte lineage and myelopoiesis in the BM remain to be262
determined, these molecules (e.g., IL-1α, IL-1β, IL-6, IL-8, TNF-α, IFN-γ, thrombopoietin263
[TPO] and G-CSF) are increased in the plasma of P. vivax patients [15, 21, 24, 73, 78, 82-84].264
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Increased cytokine levels inducing myeloid-biased HSC differentiation while reducing265
lymphopoiesis could explain the normal counts of myeloid cells and decrease of lymphocytes266
in the circulation in P. vivax patients [21, 24, 73, 78]. Indeed, less differentiated neutrophils267
(band cells) in peripheral blood are increased in P. vivax patients during acute infection,268
possibly as a result of rapid neutrophil production and/or their premature release from the269
BM [78, 79]. Likewise, elevated levels of cytokines inducing megakaryocyte differentiation270
indicates that the BM mounts a response to compensate reduced platelet counts in peripheral271
blood. Analysis of a BM biopsy from a patient with chronic vivax malaria revealed272
hyperplasia of myeloid and megakaryocytic cells [24], and a similar phenotype has been273
described in P. cynomolgi-infected monkeys [74]. In the rodent malaria model P. chabaudi it274
was demonstrated that IFN-γ signalling in hematopoietic progenitors induces myeloid-biased275
differentiation and myeloid cell numbers, which appeared to be associated with parasite276
clearance [85]. A similar mechanism was also observed in the P. berghei rodent malaria277
model [86]. The analysis of P. cynomolgi infection in Rhesus macaques also demonstrated278
transcriptomic changes in the BM including upregulation of IFN-γ and IL-27, as well as279
pathways related to pathogen recognition, such as TLRs, NOD-like receptors and RIG-280
1/MDA5 [74]. Of note, reticulocytes express parasite antigens via human leukocyte antigen281
class I (HLA-1), which are recognized by antigen-specific CD8+ T cells, resulting in the282
formation of immunological synapses and killing of the P. vivax–infected reticulocytes [87].283
Collectively, these observations suggest that P. vivax antigens can be presented and284
induce immune responses in the extravascular niches of the BM. Resident cells including285
haematopoietic progenitor/stem cell (HPSCs) could adapt to these signals through286
proliferation, mobilization from the BM and skewing toward the myeloid lineage, at the287
expense of lymphopoiesis [82-84] (Figure 3, Key Figure). However, this infection-induced288
adaptation toward enhanced myelopoiesis might also perpetuate inflammation in chronic or289
repeated infections by generating a feed-forward loop between myeloid-biased HSPCs and290
the inflammatory response. Indeed, chronic HSPC activation by infection and/or291
inflammatory stimuli causes impairment of function and exhaustion, alters global patterns of292
gene expression skewing hematopoietic potential and further perpetuates inflammation,293
which leads to BM remodelling and potentially myelodysplastic syndromes [84]. It will be294
important to investigate acute and long-term impacts of P. vivax infection in the BM, in295




Recent studies have demonstrated that the haematopoietic niche represents a major reservoir299
for P. vivax that is subject to significant changes during infection. These observations raise a300
series of questions with regards to parasite biology (see Outstanding questions). In addition,301
the host-parasite interactions established in the different reservoirs and their clinical302
implications represent key knowledge gaps. Because P. vivax develops/accumulates in the303
BM parenchyma, its antigens and parasite-induced cytokines can potentially be sensed by304
HSPCs, MSCs, ECs and mature immune cells in the BM parenchyma and shape its function.305
This raises questions about the underlying host-parasite interactions in hematopoietic stem306
cell niche environments (see Outstanding questions). Understanding the acute and long-term307
effects of the hidden parasite biomass in haematopoietic reservoirs is relevant to the study of308
acute and chronic P. vivax infection. In addition, NHP models and human cohort studies309
(autopsies, BM and/or spleen aspirates – see Box 1) will be of great value to further evaluate310
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Box 1: BM aspiration in the clinical routine522
523
BM biopsy is performed routinely as part of the clinical management of malaria patients with524
anaemia (Hb<7g/dl) to exclude other aetiologies, such as erythroid hyperplasia. The current525
knowledge gaps reported in this review are due, in part, to the fact that BM biopsy is often526
perceived as being associated with unnecessary risks for the patients and is therefore seldom527
performed on conscious individuals with mild illness. A study conducted in 2001-2003 and528
surveying about 20,000 BM aspiration/biopsy procedures across 63 hospitals reported only529
sixteen adverse events, representing 0.08% of total reported procedures and suggesting that530
risks are, in fact, minimal [88]. Larger studies with serial BM biopsies and/or aspirations531
from patients infected with P. vivax (pre/post treatment, for example) should therefore be532
considered in the future to shed more light on the BM “ecosystem” in vivax malaria.533
534
Figure 1: P. vivax tissue distribution in non-human primates (NHPs). (A) Representative535
images obtained by Obaldia et al. [32] of parasites in the immunohistochemistry (IHC)536
analysis of bone marrow, liver, lung and brain. pLDH (total), PvLAP5 (gametocytes), and537
PvAMA1 (schizonts) antibodies were used to detect stage-specific parasites; CD31538
antibodies stained the endothelium. Black arrowheads mark parasites. (B) Representative539
images obtained by Peterson et al. [34] of H&E-stained sections of bone marrow from a540
splenectomized animal and the spleen from the intact animal indicating the distribution of541
parasites (black arrows). (C-E) Heatmaps representing total, schizonts or gametocytes542
distributions in similar organs analyzed in 3 different studies: (C) Freemont et al. [33], (D)543
Obaldia et al. [32] and (E) Peterson et al. [34].544
545
Figure 2: Comparison blood- and sporozoite-inoculation on experimental P. vivax546
infection dynamics. (A) Average parasitaemia curves of blood- (red line) and sporozoite-547
inoculated (blue line) P. vivax infections (St. Elizabeth strain) are highly similar for the first548
1-2 months (solid lines) before they start to diverge, partially driven by relapses in549
sporozoite-inoculated individuals (Nblood=92, Nsporozoite=88). (B) Individual infection550
timeseries of P. vivax (St. Elizabeth strain) infected individuals, illustrating recurrent551
parasitaemias even in blood-inoculated infections (patient numbers S12 and S273, top and552
middle graph), especially following sub-curative drug treatment (arrows), and liver relapse553
following absence of peripheral parasites for ~ 2 weeks (patient number S484, bottom graph).554
Data courtesy of G. M. Jeffery and W. E. Collins.555
556
16
Figure 3, Key Figure: Potential P. vivax-induced immune responses in the bone marrow.557
Resident bone marrow cells, including hematopoietic stem cells (HSCs), multi-potent558
progenitors (MPPs) and endothelial cells express pathogen-recognition receptors (PRRs),559
such as Toll-like receptors (TLRs). This allows them to directly sense parasite-derived560
products presented by local antigen-presenting cells (APCs) or even infected immature561
reticulocytes, which still retain the capacity to present antigens via human leukocyte antigen562
class I. This would stimulate the release of cytokines such as IL-6 and G-CSF, which along563
with other cytokines that are produced during the course of infection, such as IL-1, IFNs and564
M-CSF, could act directly in the BM cells. This would promote HSC proliferation, myeloid-565
biased differentiation and also act in the granulocyte-monocyte progenitors (GMPs) and566
promote generation of myeloid cells.567
